Open call for companies 2019 – Paris Region

 

If awarded, you will:

  • Co-develop and validate the solution within the GHU Paris, GCSMS 91 or FOCH Hospital and GIP RESAH.
  • Receive funding up to 60.000€ [40.000€ for Challenges 1 to 4 and 60.000€ for Challenge 5, completed with a maximum funding...
More

Adrenomed AG announces publication of Phase II trial design of Adrecizumab to treat septic shock

Adrenomed AG, the vascular integrity company, today announced that the Phase II clinical trial design of AdrenOSS-II was published by the peer-reviewed open access journal BMJ Open. The currently ongoing Phase II trial is conducted to assess the...

More

Christine Goffinet studies the language of viruses

Since the beginning of February this year, Christine Goffinet has been the BIH Professor of Virology at the Berlin Institute of Health (BIH) and the Institute of Virology at Charité – Universitätsmedizin Berlin. She is conducting research into the...

More

Ausschreibung - “Stress reduction of patients, submitted to hospital surgical interventions, during the entire care path”

 

Das von Horizon 2020 geförderte Projekt STARS "Empowering Patients by Professional Stress Avoidance and Recovery Services" wird die Ausschreibung am 1. Februar 2019 veröffentlichen. Die Frist für die Einreichung von Vorschlägen endet am 30. April...

More

Digital attack on cancer

Several research groups at Berlin Institute of Health (BIH) are working on digitally combating cancer. The main goal is to combine and jointly evaluate existing information. With 500,000 new cancer cases every year in Germany alone, it is worthwhile...

More

How the immune system protects us against bowel cancer

Researchers from Charité – Universitätsmedizin Berlin have discovered a protective mechanism which is used by the body to protect intestinal stem cells from turning cancerous. The body’s innate immune system was found to play a pivotal role in this...

More

IMI2 - Call 17

Call ID: H2020-JTI-IMI2-2019-17-two-stage

Action Type: RIA – Research and Innovation Actions

More

Call for Tender “Stress reduction of patients, undergoing surgical interventions, during the entire care path”

Be aware and apply!

More

CRISPR Therapeutics and ProBioGen Sign Collaboration and License Agreement to Develop Novel In Vivo Delivery Technologies

 

CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, and ProBioGen, a premier German service and technology provider, today announced a multi-year research...

More
Show more items